Literature DB >> 737892

The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.

E Farram, H Festenstein, L de Giorgi.   

Abstract

An in vitro technique for detecting anti-tumour responses was studied and shown to involve non- T cells. Further examination of the effector mechanism revealed that tumour inhibition was antibody mediated, probably through complement dependent lysis; ADCC was considered unlikely. The amount of antibody involved was small, as shown by indirect immunofluorescence labelling of tumour cells, but was nevertheless effective in vitro and in causing regression of tumours in vivo. These findings may have important implications for the manipulation of the host responses to tumours.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737892      PMCID: PMC1537444     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Inhibition of the mixed lymphocyte culture by peritoneal exudate cells.

Authors:  B R Fernbach; H Kirchner; R B Herberman
Journal:  Cell Immunol       Date:  1976-03-15       Impact factor: 4.868

Review 2.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

3.  Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice.

Authors:  E Chia; H Festenstein
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Cytostasis of lymphoma cells in suspension: probable non-thymic origin of the cytostatic lymphoid cells in mice bearing mys -induced tumors.

Authors:  A Senik; L de Giorgi; E Gomard; J P Levy
Journal:  Int J Cancer       Date:  1974-09-15       Impact factor: 7.396

6.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.

Authors:  I C MacLennan; G Loewi; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

7.  Serologic approaches to the study of cancer in animals and in man.

Authors:  L J Old; E A Boyse; G Geering; H F Oettgen
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

8.  Complement enhances antiviral antibody-dependent cell cytotoxicity.

Authors:  B T Rouse; A S Grewal; L A Babiuk
Journal:  Nature       Date:  1977-03-31       Impact factor: 49.962

9.  A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cutotoxicity. II. Mechanism.

Authors:  V Schirrmacher; P Halloran; E Ross; H Festenstein
Journal:  Cell Immunol       Date:  1975-04       Impact factor: 4.868

10.  Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate.

Authors:  S C Bansal; R Hargreaves; H O Sjögren
Journal:  Int J Cancer       Date:  1972-01-15       Impact factor: 7.396

View more
  2 in total

1.  Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

2.  "Sneaking through": a T-cell-dependent phenomenon.

Authors:  P A Gatenby; A Basten; P Creswick
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.